Related Experiment Video
Updated: Jun 5, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Prescribing Patterns in Fatal Intoxications Involving Zopiclone and Alprazolam: An Observational Register-Based Study
Lova Tralla1,2, Sara Gustavsson2, Carl Söderberg2
1Division of Clinical Chemistry and Pharmacology, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Background:
Zopiclone was recently identified as a frequent contributor to fatal drug-intoxications in Sweden. However, characteristics of misuse and factors associated with prescribed use remain insufficiently described. Alprazolam has a more established misuse profile.
Objective:
The aim of the study was to describe and compare characteristics of fatal intoxications positive for zopiclone or alprazolam, focusing on prescription status and factors associated with prescribed drug use.
Methods:
Fatal intoxications between 2012 and 2020 with zopiclone and/or alprazolam in blood were identified using the Swedish Cause of Death Register and the Swedish forensic medicine database. Prescriptions within 1 year before death, and health and sociodemographic data were obtained from national registers.
Results:
Among 1270 zopiclone cases, 84% were prescribed users compared to 22% of 1532 alprazolam cases. For both substances, prescribed use was associated with female sex (zopiclone: aOR = 1.68, 95% CI = 1.22-2.30; alprazolam: aOR = 2.04, 95% CI = 1.54-2.71), suicide relative to accidental intoxication (zopiclone: aOR = 1.61, 95% CI = 1.11-2.33; alprazolam: aOR = 3.21, 95% CI = 2.16-4.75) and age ≥ 46 years (zopiclone: aOR = 2.26, 95% CI = 1.45-3.54; alprazolam: aOR = 3.20, 95% CI = 2.29-4.46). Psychiatry-contact and previous self-harm were associated with prescribed zopiclone use, but not alprazolam.
Conclusion:
Fatal intoxications involving zopiclone differ from alprazolam. While factors associated with prescribed use were often shared, substance-specific preventative strategies could be beneficial.
Related Concept Videos
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
CNS Depressants: Barbiturates and Benzodiazepines
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Barbiturates
Management of Insomnia
